Cargando…
Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia
Paediatric acute myeloid leukaemia (AML) is a heterogeneous disease characterised by the malignant transformation of myeloid precursor cells with impaired differentiation. Standard therapy for paediatric AML has remained largely unchanged for over four decades and, combined with inadequate understan...
Autores principales: | Cairns, Lauren V., Lappin, Katrina M., Mutch, Alexander, Ali, Ahlam, Matchett, Kyle B., Mills, Ken I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468645/ https://www.ncbi.nlm.nih.gov/pubmed/34576326 http://dx.doi.org/10.3390/ijms221810163 |
Ejemplares similares
-
A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia
por: Lappin, Katrina M., et al.
Publicado: (2020) -
Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics
por: Ali, Ahlam A., et al.
Publicado: (2023) -
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia
por: Aung, Myint Myat Khine, et al.
Publicado: (2021) -
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy
por: Hay, Jodie F., et al.
Publicado: (2017) -
PB1779: DEVELOPING NOVEL SYNERGISTIC DRUG COMBINATIONS WITH VENETOCLAX IN ACUTE MYELOID LEUKAEMIA
por: Harrigan, R., et al.
Publicado: (2022)